thumbnail image

#NPGS

  • HOME
  • ABOUT
  • SPEAKERS
  • AGENDA
  • SUPPORTERS
  • VIDEO LIBRARY
  • …  
    • HOME
    • ABOUT
    • SPEAKERS
    • AGENDA
    • SUPPORTERS
    • VIDEO LIBRARY

    #NPGS

    • HOME
    • ABOUT
    • SPEAKERS
    • AGENDA
    • SUPPORTERS
    • VIDEO LIBRARY
    • …  
      • HOME
      • ABOUT
      • SPEAKERS
      • AGENDA
      • SUPPORTERS
      • VIDEO LIBRARY
      • TIME ZONES

      • How to prepare for the 2022 symposium


        Neuroblastoma Basics: Dr. Ami Desai from the University of Chicago's Comer Children's Hospital provides a thorough overview of the biology of neuroblastoma, staging, treatment - particularly aimed at newly diagnosed families.

      • Gallery

        Photos & videos from our travels.

      • NPGS 2022 Agenda

         

      • Friday 11 November

        Welcome

        14:00 London Time

         

        Dr. Daniel Morgenstern will welcome you to the event, provide a quick overview of the event platform resources and kick off the event wth the first session.

        TREATING HIGH-RISK NEUROBLASTOMA IN 2022 - Where Are We Now? 

        14:05 -14:30 London Time

         

        Dr. Daniel Morgenstern will give participants an overview of the current landscape for treating high-risk neuroblastoma.

        THE CHALLENGE OF CURING HIGH-RISK NEUROBLASTOMA

        14:30 -16:20 London Time

         

        • Finding the right treatment, for the right patient with Dr. Jan Molenaar
        • Chemoimmunotherapy, a major breakthrough? with Dr. Rajen Mody
        • Is an extended induction right for some patients? with Dr. Sara Federico
        • High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes, 2022 ASCO publication, with Dr. Steve DuBois
        Followed by a 45 minute Q&A.
        Moderated by Donna Ludwinski.

        CAR-T CELL THERAPIES - Where Are We Now? 

        16:35 -18:25 London Time

         
        • Optimising CAR-T cells against neuroblastoma with Dr. John Anderson
        • GD2 specific CAR and interleukin-15 expressing autologous NKT cells with Dr. Andras Heczey
        • PHOX2B peptide-specific CAR-T cells with Dr. Mark Yarmarkovich
        • GPC2 CAR for neuroblastoma with Dr. Rosa Nguyen
        Followed by a 45 minute Q&A.
        Moderated by Antonia Palmer

        SPECIAL INTEREST TALK - Anti-GD2

        18:40 -19:30 London Time

         

        Gregory Sizikov will host this special interest talk with Dr. Robbie Majzner, looking at Anti-GD2, what do we know, what do we still need to understand, what about children without GD2 expression.

        SPECIAL INTEREST TALK - TBA

        18:40 -19:30 London Time

         

        Jude Sibley will host this special interest talk on survival.

        Wrap Up

        19:30 London Time

         

        Dr. Daniel Morgenstern provides a summary of the day's presentations and the event closes with a moving tribute to neuroblastoma children from around the world.
      •  

      Contact Us

      SKC UK Privacy Policy

      SKC US Privacy Policy

      NPGS Video Library

      © 2021

        Cookie Use
        We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
        Learn More